EDAP TMS SA (EDAP) - Total Liabilities

Latest as of December 2025: $59.58 Million USD

Based on the latest financial reports, EDAP TMS SA (EDAP) has total liabilities worth $59.58 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EDAP TMS SA (EDAP) cash conversion ratio to assess how effectively this company generates cash.

EDAP TMS SA - Total Liabilities Trend (1997–2025)

This chart illustrates how EDAP TMS SA's total liabilities have evolved over time, based on quarterly financial data. Check EDAP TMS SA asset resilience ratio to evaluate the company's liquid asset resilience ratio.

EDAP TMS SA Competitors by Total Liabilities

The table below lists competitors of EDAP TMS SA ranked by their total liabilities.

Company Country Total Liabilities
Yao Sheng Electronic Co Ltd
TWO:3207
Taiwan NT$1.90 Billion
Info-Tek
TWO:8183
Taiwan NT$3.75 Billion
Showbox Corp
KQ:086980
Korea ₩28.78 Billion
BHMINESLTD FPO [BHM]
AU:BHM
Australia AU$20.37 Million
TON Strategy Co
NASDAQ:TONX
USA $22.42 Million
China National Accord Medicines Corp Ltd
SHE:200028
China HK$29.01 Billion
Bank Negara Indonesia Tbk
JK:BBNI
Indonesia Rp1036.47 Trillion
Equillium Inc
NASDAQ:EQ
USA $3.57 Million

Liability Composition Analysis (1997–2025)

This chart breaks down EDAP TMS SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EDAP TMS SA (EDAP) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.54 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.07 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.75 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EDAP TMS SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EDAP TMS SA (1997–2025)

The table below shows the annual total liabilities of EDAP TMS SA from 1997 to 2025.

Year Total Liabilities Change
2025-12-31 $59.58 Million +31.92%
2024-12-31 $45.17 Million +30.45%
2023-12-31 $34.62 Million +17.40%
2022-12-31 $29.49 Million +8.55%
2021-12-31 $27.17 Million -6.13%
2020-12-31 $28.95 Million +12.58%
2019-12-31 $25.71 Million +8.13%
2018-12-31 $23.78 Million +9.37%
2017-12-31 $21.74 Million -1.81%
2016-12-31 $22.14 Million -8.33%
2015-12-31 $24.15 Million +41.96%
2014-12-31 $17.01 Million -3.28%
2013-12-31 $17.59 Million -21.06%
2012-12-31 $22.28 Million -6.52%
2011-12-31 $23.84 Million -11.84%
2010-12-31 $27.04 Million -2.74%
2009-12-31 $27.80 Million +4.23%
2008-12-31 $26.67 Million -12.70%
2007-12-31 $30.55 Million +131.93%
2006-12-31 $13.17 Million +15.40%
2005-12-31 $11.42 Million +14.96%
2004-12-31 $9.93 Million -23.18%
2003-12-31 $12.93 Million +13.16%
2002-12-31 $11.42 Million -19.73%
2001-12-31 $14.23 Million -9.08%
2000-12-31 $15.65 Million -25.44%
1999-12-31 $20.99 Million +2.58%
1998-12-31 $20.46 Million +19.74%
1997-12-31 $17.09 Million --

About EDAP TMS SA

NASDAQ:EDAP USA Medical Distribution
Market Cap
$130.06 Million
Market Cap Rank
#18284 Global
#4054 in USA
Share Price
$3.47
Change (1 day)
+4.52%
52-Week Range
$1.25 - $4.91
All Time High
$12.49
About

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU s… Read more